HighTide Therapeutics (“HighTide”) and Silexon Tech (“Silexon”) jointly announced a long-term strategic collaboration agreement in new drug research and development.
October 10, 2019
Based on Safety Data Review, DMC Recommends Continuing Trial
September 26, 2019
Julie is an industry veteran with experience spanning management consulting, investment banking and business development
September 02, 2019